Concepedia

Jeffrey Statland

JS

Statistics

Publications

79

Citations

4.5K

H-Index

35

Active since

2003

Affiliations

University of Kansas Medical Center(Current)

University of Rochester Medical Center

Johns Hopkins University

Radboud University Medical Center

Radboud University Nijmegen

Jeffrey Statland is an author at University of Kansas Medical Center specializing in medicine, muscular dystrophy, and muscle disorders.

ORCID

Publications per year

2003–2025

79

Publications

79

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

, , +4

Primary lateral sclerosis: consensus diagnostic criteria

Martin R. Turner, Richard J. Barohn, Philippe Corcia et al. · Journal of Neurology Neurosurgery & Psychiatry · 2020 · 244 citations · Full text

, , +17

Somatodendritic Kv7/KCNQ/M Channels Control Interspike Interval in Hippocampal Interneurons

J. Josh Lawrence, Fernanda Saraga, Joseph F. Churchill et al. · Journal of Neuroscience · 2006 · 189 citations · Full text

, , +17

Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia

Jeffrey Statland · JAMA · 2012 · 184 citations · Full text

, , +17

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 184 citations · Full text

, , +3

1–5 of 79